Synthesis and biological evaluation of some new benzimidazoles derivatives 4'-{5- amino-2-[2-substituted-phenylamino)-phenyl-methyl]-benzimidazol-1 ylmethyl}- biphenyl-2-carboxylic acid: Nonpeptide angiotensin II receptor antagonists

Authors

  • Mukesh C. Sharma Dept. of Pharmaceutical Sciences, Dr.Hari Singh Gour University Sagar (M.P) 470003 India
  • Dharm V. Kohli Dept. of Pharmaceutical Sciences, Dr.Hari Singh Gour University Sagar (M.P) 470003 India
  • Smita Sharma Department of Chemistry Yadhunath Mahavidyalya Bhind (M.P) 477001 India

Keywords:

Benzimidazoles, Biphenyl Carboxylic acid, Angiotension-II

Abstract

A new series of non peptide angiotensin (A-II) receptor antagonist has been prepared. This N-(biphenyl methyl) imidazoles e.g. Some new 4'-{5-amino- 2-[2-substituted-phenylamino)-phenyl-methyl]-benzimidazol-1-ylmethyl}- biphenyl-2-carboxylic acid derivatives were synthesized by 2-( α -hydroxy benzyl) benzimidazole was converted to 2-(α-bromo benzyl) benzimidazole by reacting with HBr and Anhydrous ZnCl2 Schiff bases react with biphenyl carboxylic acid with different substituents amino group cyclocondensation with appropriate reagents. Differ from the previously reported and related compounds in that they produce a potent hypertensive effect. The compounds synthesized were identified by 1H NMR, 13C NMR, FAB Mass and FT-IR spectroscopic techniques. All compounds studied in this work were screened for their antihypertensive activity by tail cuff method and direct method measurement of blood pressure.

References

Ferrario CM. The Renin-Angiotensin System:

Importance in Physiology and Pathology. J

Cardiovasc Pharmacol 2004; 15: 51-55.

Vallotton M. B. The Renin-Angiotensin System.

Trends Pharmacol. Sci 1987; 8, 69.

Nahmias C, Strosberg A. D. The angiotensin AT2

Receptor: Searching for Signal-Transduction

Pathways and Physiological Function. Trends

Pharmacol Sci 1995; 16, 223-225.

Berecek KH, King SJ, Wu JN. AngiotensinConverting Enzyme and Converting Enzyme

Inhibitors. Cellular and Molecular Biology of the

Renin-Angiotensin System; CRC Press: Boca

Raton, FL 1993; 183-220.

Kleinert HD. Recent Developments in Renin

Inhibitors. Exp. Opin. Invest. Drugs 1994; 3:

-1104.

Dutta AS. Design and Therapeutic Potential of

Peptides. In Advances in Drug Research; Testa,

B., Ed.Academic Press: London, 21, 1991; 147-

(a) McEwan JR, Fuller RW. Angiotensin

Converting Enzyme Inhibitors and Cough. J.

Cardiovasc. Pharmacol 1989;13: S67-S69. (b)

Skidgel RA, Engelbrecht S, Johnson AR, Erdos

EG. Hydrolysis of Substance P and Neurotensin

by Converting Enzyme and Neutral

Endopeptidase. Peptides. 1984;5: 769-776.

Y. Furukawa, S.Kishimoto, S.Nishikawa. U.S.

Patent 4340598, 1982.

Carini DJ, Duncia JV, Aldrich PE, Chiu AT,

Johnson AL, Pierce ME, Price WA, Santella JB,

Wells GJ, Wexler RR, Wong PC, Yoo SE,

Timmermans PB. Nonpeptide Angiotensin II

Receptor Antagonists: The Discovery of a Series

of N-(Biphenylylmethyl)imidazoles as Potent,

Orally Active Antihypertensive. J Med Chem

; 34: 2525-2547.

Bali A, Bansal Y, Sugumaran M, Saggu JS,

Balakumar P, Kaur G, Bansal G, Sharma A, Singh

M. Design, synthesis and evaluation of novelly

substituted benzimidazole compounds as

angiotensin II receptor antagonists. Bioorg Med

Chem Lett 2005;15: 3962-3965.

Dhvanit I. S, Sharma M, Bansal Y,Bansal G,

Singh M. Angiotensin II AT1 receptor antagonists:

Design, synthesis and evaluation of substituted

carboxamido benzimidazole derivatives European

Journal of Medicinal Chemistry 2008;43: 1808-

Jat RK, Jat JL, Pathak DP. Synthesis of

Benzimidazole Derivatives: As Anti-hypertensive

Agents.E Journal of Chemistry 2006;3: 278-285.

Preston, Heterocyclic Compounds:

Benzimidazoles and Congeneric Tricyclic

compounds, Part-I, Vol-40, p-7.

Solomon Marmor, Laboratory methods in Organic

Chemistry, Surjeet publications, 1986: 284-285.

Badyal DK, Lata H, Dadhich AP. Animal models

of hypertension and effect of drugs. Indian J of

Pharmacology 2003; 35: 349-362.

Bunag RD, McCubbin JW, Page IH. Lack of

correlation between direct and indirect

measurements of arterial pressure in

unanaesthetized rats. Cardiovasc Res 1971;5: 24-

Gupta SK. Drug Screening methods, Jaypee

Brothers Medical Publisher, New Delhi,2004;

-246.

Shreenivas MT, Chetan BP, Bhat AR. Synthesis

and Pharmacological Evaluation of Certain Schiff

Bases and Thiazoldine Derivatives as AT1

Angiotension-II (AII) Receptor Antagonists. J

Pharm Sci Tech 2009; 1: 88-94.

Saggu JS, Sharma R, Dureja H, Kumar V.

Benzimidazoles with biphenyls: Synthesis of 5-

substituted-2-npropyl- 1-[(2’-carboxybiphenyl-4-

yl-) methyl] benzimidazoles. J Indian Inst Sci

;82: 177–182.

Fieser M, Fieser L. Reagents for organic

synthesis. 1969; 2: 389.

Bunag RD, McCubbin JW, Page IH. Lack of

correlation between direct and indirect

measurements of arterial pressure in

unanaesthetized rats. Cardiovascular Res. 1971; 5:

-31.

Siddiqui AA, Wani MS. Indian J Chemistry.

; 43B: 1574, 1579.

Downloads

Published

2010-09-30

How to Cite

Mukesh C. Sharma, Dharm V. Kohli, & Smita Sharma. (2010). Synthesis and biological evaluation of some new benzimidazoles derivatives 4’-{5- amino-2-[2-substituted-phenylamino)-phenyl-methyl]-benzimidazol-1 ylmethyl}- biphenyl-2-carboxylic acid: Nonpeptide angiotensin II receptor antagonists. International Journal of Drug Delivery, 2(3), 265–277. Retrieved from https://ijdd.arjournals.org/index.php/ijdd/article/view/39

Issue

Section

Original Research Articles